A structural and dynamic model for the interaction of interleukin-8 and glycosaminoglycans: support from isothermal fluorescence titrations.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMID 14997572)

Published in Proteins on March 01, 2004

Authors

Elmar Krieger1, Elena Geretti, Barbara Brandner, Birgit Goger, Timothy N Wells, Andreas J Kungl

Author Affiliations

1: Centre for Molecular and Biomolecular Informatics, Nijmegen, The Netherlands.

Articles citing this

GLYCAM06: a generalizable biomolecular force field. Carbohydrates. J Comput Chem (2008) 4.51

Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer. Matrix Biol (2010) 1.21

Characterization of the interaction of interleukin-8 with hyaluronan, chondroitin sulfate, dermatan sulfate and their sulfated derivatives by spectroscopy and molecular modeling. Glycobiology (2011) 1.07

Heparin-induced cis- and trans-dimerization modes of the thrombospondin-1 N-terminal domain. J Biol Chem (2007) 1.00

Solution NMR characterization of chemokine CXCL8/IL-8 monomer and dimer binding to glycosaminoglycans: structural plasticity mediates differential binding interactions. Biochem J (2015) 0.92

Docking glycosaminoglycans to proteins: analysis of solvent inclusion. J Comput Aided Mol Des (2011) 0.91

The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization. Glycobiology (2015) 0.91

Molecular requirements for sorting of the chemokine interleukin-8/CXCL8 to endothelial Weibel-Palade bodies. J Biol Chem (2009) 0.86

Functional aspects of the interaction between interleukin-8 and sulfated glycosaminoglycans. Biomatter (2013) 0.85

A surface plasmon resonance-based solution affinity assay for heparan sulfate-binding proteins. Glycoconj J (2008) 0.84

Structure-based design of decoy chemokines as a way to explore the pharmacological potential of glycosaminoglycans. Br J Pharmacol (2012) 0.81

Designing "high-affinity, high-specificity" glycosaminoglycan sequences through computerized modeling. Methods Mol Biol (2015) 0.79

Designing CXCL8-based decoy proteins with strong anti-inflammatory activity in vivo. Biosci Rep (2013) 0.76

Interaction of the interleukin 8 protein with a sodium dodecyl sulfate micelle: A computer simulation study. J Mol Model (2017) 0.75

Articles by these authors

Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood (2010) 4.96

Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med (2009) 2.15

Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo. J Biol Chem (2004) 1.69

A proteomic snapshot of the human heat shock protein 90 interactome. FEBS Lett (2005) 1.33

Role of CCL5 (RANTES) in viral lung disease. J Virol (2006) 1.21

Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites. Biochemistry (2002) 1.16

Structural basis for selective inhibition of Mycobacterium tuberculosis protein tyrosine phosphatase PtpB. Structure (2007) 1.10

A new monocyte chemotactic protein-1/chemokine CC motif ligand-2 competitor limiting neointima formation and myocardial ischemia/reperfusion injury in mice. J Am Coll Cardiol (2010) 1.09

The molecular chaperone Hsp90 modulates intermediate steps of amyloid assembly of the Parkinson-related protein alpha-synuclein. J Biol Chem (2009) 1.05

Interleukin-8 binds to syndecan-2 on human endothelial cells. Biochem J (2004) 0.98

A proteomic approach towards the Hsp90-dependent ubiquitinylated proteome. Proteomics (2007) 0.98

HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicity. Toxicol Appl Pharmacol (2012) 0.96

Rationally evolving MCP-1/CCL2 into a decoy protein with potent anti-inflammatory activity in vivo. J Biol Chem (2010) 0.95

Engineering the glycosaminoglycan-binding affinity, kinetics and oligomerization behavior of RANTES: a tool for generating chemokine-based glycosaminoglycan antagonists. Protein Eng Des Sel (2009) 0.94

Chemokine degradation by the Group A streptococcal serine proteinase ScpC can be reconstituted in vitro and requires two separate domains. Biochem J (2009) 0.93

A biophysical insight into the RANTES-glycosaminoglycan interaction. Biochim Biophys Acta (2009) 0.90

A novel CXCL8 protein-based antagonist in acute experimental renal allograft damage. Mol Immunol (2009) 0.89

Investigating the effect of VEGF glycosylation on glycosaminoglycan binding and protein unfolding. Biochem Biophys Res Commun (2005) 0.89

Selective binding and presentation of CCL5 by discrete tissue microenvironments during renal inflammation. J Am Soc Nephrol (2007) 0.87

Proteoglycanomics: tools to unravel the biological function of glycosaminoglycans. Proteomics (2007) 0.86

The basic residue cluster (55)KKWVR(59) in CCL5 is required for in vivo biologic function. Mol Immunol (2009) 0.84

Glycanogenomics: a qPCR-approach to investigate biological glycan function. Biochem Biophys Res Commun (2008) 0.83

Comparative membrane proteome analysis of three Borrelia species. Proteomics (2012) 0.83

New targets for glycosaminoglycans and glycosaminoglycans as novel targets. Expert Rev Proteomics (2013) 0.82

SERF protein is a direct modifier of amyloid fiber assembly. Cell Rep (2012) 0.81

Structure-based design of decoy chemokines as a way to explore the pharmacological potential of glycosaminoglycans. Br J Pharmacol (2012) 0.81

Proteomic profiling of human stem cells derived from umbilical cord blood. Biochem Biophys Res Commun (2005) 0.80

Glycomic approaches toward drug development: therapeutically exploring the glycosaminoglycanome. Curr Opin Mol Ther (2006) 0.80

The neurotransmitter serotonin interrupts α-synuclein amyloid maturation. Biochim Biophys Acta (2011) 0.79

Biophysical investigation of recombinant K5 lyase: structural implications of substrate binding and processing. Biochim Biophys Acta (2006) 0.79

Preliminary 2-D chromatographic investigation of the human stem cell proteome. Biochem Biophys Res Commun (2003) 0.79

Single-cell quantitative HER2 measurement identifies heterogeneity and distinct subgroups within traditionally defined HER2-positive patients. Am J Pathol (2013) 0.78

Lessons from the stem cell proteome. Curr Stem Cell Res Ther (2006) 0.77

Antimycobacterial and H1-antihistaminic activity of 2-substituted piperidine derivatives. Bioorg Med Chem (2008) 0.77

Designing CXCL8-based decoy proteins with strong anti-inflammatory activity in vivo. Biosci Rep (2013) 0.76

Unfolding and double-stranded DNA binding of the cold shock protein homologue Cla h 8 from Cladosporium herbarum. J Biol Chem (2002) 0.76

Biophysical investigation of human heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3A: a mutual effect of enzyme oligomerisation and glycosaminoglycan ligand binding. Biochim Biophys Acta (2007) 0.76

Coimmunoprecipitation and proteomic analyses. Methods Mol Biol (2008) 0.76

Novel svVEGF isoforms from Macrovipera lebetina venom interact with neuropilins. Biochem Biophys Res Commun (2009) 0.75

Antimycobacterial activity of diphenylpyraline derivatives. Eur J Med Chem (2007) 0.75

Chemokine receptor CCR5 is not required for development of experimental autoimmune gastritis. Clin Immunol (2003) 0.75